Evidence map›Paper›PMID 40835904›Full record

ArticleBMC bioinformatics2025

Learning-based parallel acceleration for HaplotypeCaller.

Xiangxing Lai, Minguang Xiao, Lingling Weng, Zhiguang Chen

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiangxing LaiSchool of Computer Science and Engineering, Sun Yat-sen University, Waihuan Dong Road, Guangzhou, 510006, China.
Minguang Xiao *National Supercomputer Center in Guangzhou, Xiaoyuan Dong Road, Guangzhou, 510330, China.
Lingling Weng *National Supercomputer Center in Guangzhou, Xiaoyuan Dong Road, Guangzhou, 510330, China.
Zhiguang ChenSchool of Computer Science and Engineering, Sun Yat-sen University, Waihuan Dong Road, Guangzhou, 510006, China. chenzhg29@mail.sysu.edu.cn.

Funding

Guangdong S&T Program 2024B0101040005the Guangdong Province Special Support Program for Cultivating High-Level Talents 2021T006X160the National Natural Science Foundation of China 62272499
6 · The paper itself

Abstract

In the genome analysis workflow, Genome Analysis Toolkit (GATK) HaplotypeCaller is a widely used variant calling tool designed to accurately identify single nucleotide polymorphisms (SNPs) and insertions/deletions (Indels) in samples. However, when processing large-scale datasets, HaplotypeCaller often faces the challenge of excessively long runtime. Parallelizing GATK HaplotypeCaller with data segmentation is an effective solution, but existing methods struggle to accurately estimate the computational complexity of each data block, leading to severe computational skew. This paper introduces a learning-based framework LPA (learning-based parallel acceleration), leveraging model to accurately predict the computational complexity of data. By employing adaptive data segmentation algorithms and Multi-Knapsack Problem (MKP) based task scheduling, LPA significantly alleviates computational skew. We evaluated LPA in multiple datasets, demonstrating that its execution speed is 30x–40x faster than HaplotypeCaller and 2x–5x faster than HaplotypeCallerSpark. LPA achieves a speedup of 1.3x–2x compared to similar methods. And LPA maintaining a high accuracy with over 99.9%, enhancing the efficiency and reliability of variant calling. The source code of LPA is publicly available at https://github.com/laixx9/LPA .

Indexed as

GenomicsHaplotypesMachine LearningSoftwareAlgorithmsINDEL MutationParallel AlgorithmsPolymorphism, Single NucleotideAccelerationHaplotypeCallerLearningParallel

Identifiers

PMID40835904
PMCPMC12366067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.